 |
SparingVision
Last updated: May 01, 2024
CEO Stéphane Boissel
Country: France | Funding: $127.6M (+)
Website: https://sparingvision.com
SparingVision is a biotechnology company focused on the discovering and development of an innovative, therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa.
Website: https://sparingvision.com
SparingVision is a biotechnology company focused on the discovering and development of an innovative, therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa.
